Max India Limited Appoints Former McKinsey Senior Partner Mrinalini Mirchandani as Independent Director

1 min read     Updated on 10 Apr 2026, 03:07 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Max India Limited's Board of Directors approved the appointment of Ms. Mrinalini Mirchandani as Additional Independent Director for a five-year term from April 15, 2026 to April 14, 2031. Ms. Mirchandani, a former Senior Partner at McKinsey & Company and the first woman to hold this position in the firm's 34-year India history, brings extensive experience in private equity, healthcare, and strategic consulting. The appointment, subject to shareholder approval, complies with SEBI listing regulations.

powered bylight_fuzz_icon
37316230

*this image is generated using AI for illustrative purposes only.

Max India Limited has announced the appointment of Ms. Mrinalini Mirchandani as Additional Director in the capacity of Independent Director. The Board of Directors approved this appointment on April 9, 2026 via circular resolution, following the recommendation of the Nomination and Remuneration Committee.

Appointment Details

The appointment encompasses a five-year term commencing on April 15, 2026 and concluding on April 14, 2031. The decision is subject to approval from shareholders and has been disclosed in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Parameter: Details
Director Name: Ms. Mrinalini Mirchandani
DIN: 11619010
Position: Additional Director (Independent Director)
Term Duration: 5 years
Commencement Date: April 15, 2026
End Date: April 14, 2031
Approval Status: Subject to shareholder approval

Professional Background

Ms. Mirchandani brings distinguished experience from her tenure at McKinsey & Company, where she served as Senior Partner. She holds the distinction of being the first and only woman elected to the Senior Partner position in McKinsey's 34-year history in India.

At McKinsey, she led the Private Equity Practice in India and served as a member of the global healthcare leadership team. Her responsibilities also included overseeing the Organization & Talent practice in India. Prior to McKinsey, she worked at Merrill Lynch, leading their Healthcare & Consumer Investment Banking Team in India, and headed the Healthcare recruiting practice for Egon Zehnder in India.

Educational Qualifications and Recognition

Ms. Mirchandani holds an MBA from IIM Calcutta and a B.Com from Mumbai University. Her professional achievements were recognized in 2018 when she was featured in the Economic Times list of India's 40 under Forty Young Business Leaders.

Regulatory Compliance

The company has confirmed that Ms. Mirchandani is not related to any other Director of the Company and is not debarred from holding the office of Director by virtue of any order passed by SEBI or any other authority. The appointment disclosure complies with all requirements under SEBI listing regulations and relevant circulars.

Over the past two decades, Ms. Mirchandani has collaborated with leading Indian and global institutions on various strategic initiatives including growth strategy, mergers and acquisitions, capital raising, talent management, and delivering transformational change at scale.

Historical Stock Returns for Max India

1 Day5 Days1 Month6 Months1 Year5 Years
+3.99%+7.46%+7.98%-26.50%-9.35%+149.12%

What strategic initiatives or transformation plans might Max India be considering that would benefit from Ms. Mirchandani's private equity and healthcare expertise?

How could Ms. Mirchandani's M&A experience at McKinsey influence Max India's potential acquisition or divestiture strategies in the coming years?

Will Max India's board composition changes signal a shift toward more healthcare-focused investments or operational improvements?

Max India Limited Submits Regulatory Compliance Certificate for Q4 FY26

1 min read     Updated on 06 Apr 2026, 06:10 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Max India Limited submitted its quarterly compliance certificate to BSE and NSE for the quarter ended March 31, 2026, pursuant to SEBI Depositories Regulations. The certificate from registrar Mas Services Limited confirms timely processing of dematerialization requests, proper handling of security certificates, and adherence to 15-day regulatory timeframes for updating member registers and notifying exchanges.

powered bylight_fuzz_icon
37024847

*this image is generated using AI for illustrative purposes only.

Max India Limited has filed its quarterly compliance certificate with stock exchanges BSE and NSE, confirming adherence to regulatory requirements under SEBI depositories regulations for the quarter ended March 31, 2026.

Regulatory Filing Details

The company submitted the confirmation certificate pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. The filing was made on April 06, 2026, and addressed to both major stock exchanges where the company's shares are listed.

Parameter: Details
Filing Date: April 06, 2026
Quarter Covered: January 01, 2026 to March 31, 2026
Regulation: SEBI (Depositories and Participants) Regulations, 2018
Scrip Code (BSE): 543223
Scrip Name: MAXIND

Registrar Confirmation

The certificate was issued by Mas Services Limited, which serves as the company's Registrar and Share Transfer Agent. The registrar confirmed compliance with key dematerialization requirements during the reporting period.

Mas Services Limited certified that securities received from Depository Participants for dematerialization during the quarter were processed within the mandated 15-day timeframe. The registrar also confirmed proper handling of security certificates and timely updates to member registers.

Compliance Confirmations

The registrar's certificate outlined several critical compliance areas:

  • Timely Processing: All securities received from depository participants were confirmed (accepted/rejected) to depositories within 15 days of receipt
  • Certificate Handling: Security certificates received for dematerialization were properly mutilated and cancelled after verification
  • Register Updates: Depository names were substituted in the register of members as registered owners within the prescribed 15-day period
  • Exchange Notification: Updates were communicated to depositories and stock exchanges within the required timeframe

Corporate Information

Max India Limited operates from its corporate office in Gurgaon, Haryana, with its registered office located in New Delhi. The company's compliance officer Trapti signed the regulatory filing, ensuring proper documentation and submission to exchanges.

The filing represents routine quarterly compliance reporting required under SEBI regulations, demonstrating the company's adherence to depositories and participant regulations governing dematerialization processes.

Historical Stock Returns for Max India

1 Day5 Days1 Month6 Months1 Year5 Years
+3.99%+7.46%+7.98%-26.50%-9.35%+149.12%

Will Max India Limited's consistent regulatory compliance improve its ESG ratings and attract institutional investors in upcoming quarters?

How might SEBI's potential tightening of depositories regulations impact Max India's operational costs and compliance processes?

Could Max India's strong compliance track record position it favorably for any planned corporate actions or fundraising activities in 2026?

More News on Max India

1 Year Returns:-9.35%